Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Monday, November 23, 2009, 3:53pm SGT - The Singapore stock market closes in 1 hour and 7 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Omeros Corporation (OMER)
On Nov 21:
7.50 USD
0.20 (2.60%)
MORE ON OMER
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Omeros Corporation
(NGM:OMER) Delayed quote data
Last Trade:
7.50 USD
Trade Time:
Nov 21
Change:
0.20 (2.60%)
Prev Close:
7.70
Open:
7.42
Bid:
6.79
x 200
Ask:
N/A
1y Target Est:
12.25
Day's Range:
7.15 - 7.84
52wk Range:
5.27 - 9.49
Volume:
95,960
Avg Vol
(3m)
:
188,147
Market Cap:
22.15M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-8.68
Div & Yield:
N/A (N/A%)
1d
5d
3m
Use Y! Toolbar to track stocks
Add OMER to Portfolio
Download Data
HEADLINES
New Star Analyst Rankings for Omeros Corporation
StarMine
(Sun 10:19pm)
Coverage initiated on Omeros by Wedbush Morgan
Briefing.com
(Sat, Nov 21)
OMEROS CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online
(Fri, Nov 20)
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
PR Newswire
(Fri, Nov 20)
Q3 2009 OMEROS CORP Earnings Release - After Market Close
CCBN
(Thu, Nov 19)
Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
PR Newswire
(Fri, Nov 13)
OMEROS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online
(Thu, Nov 12)
CEO Interview: Winston Pharmaceuticals, Inc. - Dr. Joel E. Bernstein
Wall Street Transcript
(Tue, Nov 3)
Hyatt Hotels to Test the IPO Waters
at The Wall Street Journal Online
(Mon, Nov 2)
Road to Market Becomes More Difficult in the U.S.
at The Wall Street Journal Online
(Mon, Nov 2)
More Headlines for OMER...
ANALYST
EPS Est (next year)
(Dec-09)
:
-1.44
EPS Est (in 2 years)
(Dec-10)
:
-1.47
Avg Rec (current)*:
1.5
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Omeros Corporation, a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing products on inflammation and disorders of the central nervous system.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices